Overview of the Market:
Middle-East & Africa Empty Capsules Market was worth USD 172.53 million in 2018 and estimated to be growing at a CAGR of 6.31%, to reach USD 234.25 million by 2023. Empty Capsules are generally made from Gelatin, which is derived from plant or animal origin. These are used as dosage form for prescription and OTC drugs, nutrient supplements and herbal products.
Middle-East and Africa Empty Capsules Market is mainly driven due to the growing applications in pharmaceutical and nutraceutical companies. Growing consumer preference for capsule based formulations is also a key factor fuelling the market growth. However stringent regulatory approval policies and increasing raw material costs are restraining the growth of the market
Middle-East & Africa Empty Capsules market is segmented by product, therapeutic application and End User. By product the market is segmented as Gelatin Capsules and Non-Gelatin Capsules. Based on therapeutic application Middle-East & Africa market for Empty capsules is segmented into Antibiotic and Antibacterial Drugs, Antacid and Antiflatulent Preparations, Anti anemic Preparations, Anti-Inflammatory Drugs, Cardiovascular Therapy Drugs, Dietary Supplements and Vitamins, Cough and Cold Preparations and other therapeutic applications. On the basis of End User the market is segmented as Pharmaceutical Industry, Cosmetics Industry, Nutraceutical Industry and Research Laboratories.
Gelatin Capsules is the largest product segment accounting for a share of approximately 80% whereas Non-Gelatin capsules is estimated to be the fastest segment with a CAGR of XX% due to increasing preference for vegetable origin capsules. Pharmaceutical industry is the largest end user of empty gelatin capsules accounting for a share of approximately XX% and is estimated to maintain its strong share of the market during the forecast period.
Geographical Analysis:
Based on geography Middle-East & Africa market for empty capsules is analyzed under Middle-East and Africa. Within this region Middle-East accounts for the largest share of the market while Africa is estimated to be the fastest growing region
key players in the market:
Some of the major companies covered in the report are Capsugel, Acg Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co., Ltd. and Sunil Healthcare Limited
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Gelatin Capsules
5.1.2 Non Gelatin Capsules
5.2 By Therapeutic Applcation
5.2.1 Antibiotic and Antibacterial Drugs
5.2.2 Vitamins and Dietary Supplements
5.2.3 Antacid and Antiflatulent Preparations
5.2.4 Antianemic Preparations
5.2.5 Anti-Inflammatory Drugs
5.2.6 Cardiovascular Therapy Drugs
5.2.7 Cough and Cold Preparations
5.2.8 Other therapeutic applications
5.3 By End User
5.3.1 Pharmaceutical Industry
5.3.2 Nutraceutical Industry
5.3.3 Cosmetics Industry
5.3.4 Research Laboratories
6. Geographical Analysis
6.1 Introduction
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Capsugel
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Suheung Co Ltd.
8.3 Acg Worldwide
8.4 Bright Pharmacaps Inc.
8.5 Capscanada Corporation
8.6 Medi-Caps Ltd.
8.7 Qualicaps
8.8 Roxlor, LLC
8.9 Snail Pharma Industry Co., Ltd.
8.10 Sunil Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
